Cigna Corporation Company Profile (NYSE:CI)

About Cigna Corporation (NYSE:CI)

Cigna Corporation logoCigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company's segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate. Its Global Health Care segment aggregates the commercial and Government operating segments. Its commercial operating segment encompasses the United States commercial and certain international healthcare businesses serving employers and their employees, other groups, and individuals. Its Global Supplemental Benefits segment offers supplemental health, life and accident insurance products in selected international markets and in the United States. Its Group Disability and Life segment provides group long-term and short-term disability insurance, group life insurance, accident and specialty insurance and related services.

Industry, Sector and Symbol:
  • Sector: Finance
  • Industry: Managed Health Care
  • Sub-Industry: Managed Health Care
  • Symbol: NYSE:CI
  • CUSIP: 12550910
  • Web: www.cigna.com
Capitalization:
  • Market Cap: $46.86849 billion
  • Outstanding Shares: 251,778,000
Average Prices:
  • 50 Day Moving Avg: $185.32
  • 200 Day Moving Avg: $170.46
  • 52 Week Range: $115.03 - $193.00
P/E:
  • Trailing P/E Ratio: 21.34
  • Foreward P/E Ratio: 16.20
  • P/E Growth: 1.33
Sales & Book Value:
  • Annual Revenue: $40.53 billion
  • Price / Sales: 1.15
  • Book Value: $57.56 per share
  • Price / Book: 3.21
Dividend:
  • Annual Dividend: $0.04
  • Dividend Yield: 0.0%
Profitability:
  • EBITDA: $4.21 billion
  • Net Margins: 5.55%
  • Return on Equity: 17.40%
  • Return on Assets: 4.04%
Debt:
  • Debt-to-Equity Ratio: 0.32%
  • Current Ratio: 0.40%
  • Quick Ratio: 0.40%
Misc:
  • Average Volume: 1.19 million shs.
  • Beta: 0.43
  • Short Ratio: 2.3
 

Frequently Asked Questions for Cigna Corporation (NYSE:CI)

What is Cigna Corporation's stock symbol?

Cigna Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "CI."

How often does Cigna Corporation pay dividends? What is the dividend yield for Cigna Corporation?

Cigna Corporation announced a quarterly dividend on Wednesday, February 22nd. Stockholders of record on Friday, March 10th will be paid a dividend of $0.04 per share on Monday, April 10th. This represents a $0.16 annualized dividend and a dividend yield of 0.09%. The ex-dividend date of this dividend is Wednesday, March 8th. View Cigna Corporation's Dividend History.

How will Cigna Corporation's stock buyback program work?

Cigna Corporation announced that its Board of Directors has initiated a share buyback plan on Sunday, June 4th 2017, which authorizes the company to repurchase $3,700,000,000.00 in shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 9.8% of its stock through open market purchases. Stock repurchase plans are often an indication that the company's board of directors believes its shares are undervalued.

How were Cigna Corporation's earnings last quarter?

Cigna Corporation (NYSE:CI) posted its quarterly earnings data on Friday, August, 4th. The company reported $2.91 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $2.48 by $0.43. The business had revenue of $10.32 billion for the quarter, compared to the consensus estimate of $10.26 billion. Cigna Corporation had a return on equity of 17.40% and a net margin of 5.55%. The company's revenue for the quarter was up 3.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.98 earnings per share. View Cigna Corporation's Earnings History.

When will Cigna Corporation make its next earnings announcement?

Cigna Corporation is scheduled to release their next quarterly earnings announcement on Thursday, November, 2nd 2017. View Earnings Estimates for Cigna Corporation.

What guidance has Cigna Corporation issued on next quarter's earnings?

Cigna Corporation issued an update on its FY17 earnings guidance on Friday, August, 4th. The company provided earnings per share guidance of $9.75-10.05 for the period, compared to the Thomson Reuters consensus EPS estimate of $9.78.

Where is Cigna Corporation's stock going? Where will Cigna Corporation's stock price be in 2017?

14 brokerages have issued 12-month target prices for Cigna Corporation's stock. Their predictions range from $174.00 to $221.00. On average, they expect Cigna Corporation's share price to reach $190.62 in the next twelve months. View Analyst Ratings for Cigna Corporation.

What are analysts saying about Cigna Corporation stock?

Here are some recent quotes from research analysts about Cigna Corporation stock:

  • 1. According to Zacks Investment Research, "Cigna’s shares have outperformed the industry year to date. The company is poised for long-term growth on the back of its robust Global Supplemental business, growing Government business and increasing membership. A strong capital position and resumption of share buyback are other positives. The stock has seen the Zacks Consensus Estimate for current-year earnings being revised upward over the last 90 days. Cigna is engaged in a legal tussle with Anthem and thus the termination fee and other charges that it were to receive from the latter remain uncertain.  Increase in benefits and expenses continue to bother us." (10/9/2017)
  • 2. Jefferies Group LLC analysts commented, "CI reported Q2:17 adjusted EPS of $2.91 (GAAP $3.15), compared to OPCO’s estimate of $2.46 and Street consensus of $2.45. Adjusted results exclude $0.13 of realized investment gains and $0.18 from merger-related tax benefits, offset by $0.07 of amortization expense. The beat was driven by the Healthcare segment, with the Commercial MCR of 78.7% outperforming OPCO/Street estimates by 200/160 bps. Due to the beat, the company raised FY2017 EPS guidance to $9.75-$10.05 vs. $9.35-$9.85, with all three segment outlooks growing by $15-$40M." (8/4/2017)

Who are some of Cigna Corporation's key competitors?

Who are Cigna Corporation's key executives?

Cigna Corporation's management team includes the folowing people:

  • Isaiah Harris Jr., Independent Chairman of the Board
  • David M. Cordani, President, Chief Executive Officer, Director
  • Eric P. Palmer, Chief Financial Officer, Executive Vice President
  • CHRISTOPHER HOCEVAR, President, Strategy, Segments and Solutions
  • Matthew G. Manders, President - Government & Individual Programs and Group Insurance
  • Jason Dominic Sadler, President - International Markets.
  • MICHAEL TRIPLETT, is President, U.S. Markets
  • Mark L. Boxer, Global Chief Information Officer, Executive Vice President
  • Lisa R. Bacus, Executive Vice President, Chief Marketing Officer, Chief Customer Officer
  • Nicole S. Jones, Executive Vice President, General Counsel

Who owns Cigna Corporation stock?

Cigna Corporation's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Pensionfund DSM Netherlands (0.01%), Pensionfund Sabic (0.00%) and Eqis Capital Management Inc. (0.00%). Company insiders that own Cigna Corporation stock include David Cordani, Herbert A Fritch, Isaiah Harris Jr, Isaiah Harris, Jr, Jane E Md Henney, Jason D Sadler, John M Murabito, Lisa R Bacus, Mary T Hoeltzel, Matthew G Manders, Michael W Triplett, Nicole S Jones, Thomas A Mccarthy and William D Zollars. View Institutional Ownership Trends for Cigna Corporation.

Who bought Cigna Corporation stock? Who is buying Cigna Corporation stock?

Cigna Corporation's stock was acquired by a variety of institutional investors in the last quarter, including Pensionfund DSM Netherlands, Pensionfund Sabic and Eqis Capital Management Inc.. View Insider Buying and Selling for Cigna Corporation.

How do I buy Cigna Corporation stock?

Shares of Cigna Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cigna Corporation's stock price today?

One share of Cigna Corporation stock can currently be purchased for approximately $184.99.


MarketBeat Community Rating for Cigna Corporation (NYSE CI)
Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  526 (Vote Outperform)
Underperform Votes:  337 (Vote Underperform)
Total Votes:  863
MarketBeat's community ratings are surveys of what our community members think about Cigna Corporation and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Cigna Corporation (NYSE:CI) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Hold Ratings, 12 Buy Ratings
Consensus Rating:Buy (Score: 2.86)
Consensus Price Target: $190.62 (3.04% upside)
Consensus Price Target History for Cigna Corporation (NYSE:CI)
Price Target History for Cigna Corporation (NYSE:CI)
Analysts' Ratings History for Cigna Corporation (NYSE:CI)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/16/2017BMO Capital MarketsInitiated CoverageMarket PerformN/AView Rating Details
10/13/2017Jefferies Group LLCBoost Price TargetBuy$201.00 -> $221.00N/AView Rating Details
9/17/2017Piper Jaffray CompaniesReiterated RatingBuy$191.00LowView Rating Details
8/17/2017Morgan StanleyBoost Price TargetOverweight$188.00 -> $195.00LowView Rating Details
8/9/2017Royal Bank Of CanadaReiterated RatingBuy$185.00HighView Rating Details
8/7/2017Citigroup Inc.Boost Price TargetBuy$185.00 -> $198.00LowView Rating Details
8/7/2017Deutsche Bank AGBoost Price TargetBuy$180.00 -> $190.00LowView Rating Details
8/4/2017Credit Suisse GroupReiterated RatingBuy$196.00HighView Rating Details
6/23/2017Bank of America CorporationBoost Price TargetBuy$193.00 -> $198.00MediumView Rating Details
6/19/2017Wells Fargo & CompanyReiterated RatingMarket Perform$163.00 -> $174.00LowView Rating Details
6/15/2017CIBCBoost Price TargetOutperform$174.00 -> $185.00MediumView Rating Details
6/15/2017Oppenheimer Holdings, Inc.Boost Price TargetOutperform$174.00 -> $185.00LowView Rating Details
6/1/2017Cowen and CompanyReiterated RatingOutperform$160.00 -> $185.00LowView Rating Details
5/15/2017Stifel NicolausBoost Price TargetBuy$170.00 -> $175.00N/AView Rating Details
9/26/2016Leerink SwannReiterated RatingBuy$155.00N/AView Rating Details
9/22/2016Evercore ISIInitiated CoverageHold$134.00N/AView Rating Details
9/8/2016Goldman Sachs Group, Inc. (The)Reiterated RatingBuy$160.00N/AView Rating Details
8/31/2016William BlairReiterated RatingBuyN/AView Rating Details
6/28/2016Wolfe ResearchInitiated CoverageOutperform$172.00N/AView Rating Details
6/20/2016FBR & CoReiterated RatingHoldN/AView Rating Details
6/1/2016Barclays PLCBoost Price TargetEqual Weight$156.00 -> $168.00N/AView Rating Details
1/24/2016Sterne Agee CRTReiterated RatingBuyN/AView Rating Details
11/9/2015WedbushReiterated RatingHold$186.00 -> $175.00N/AView Rating Details
(Data available from 10/17/2015 forward)

Earnings

Earnings History for Cigna Corporation (NYSE:CI)
Earnings by Quarter for Cigna Corporation (NYSE:CI)
Earnings History by Quarter for Cigna Corporation (NYSE CI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2017$2.34N/AView Earnings Details
8/4/2017Q2 2017$2.48$2.91$10.26 billion$10.32 billionViewN/AView Earnings Details
5/5/2017Q1 2017$2.44$2.77$10.11 billion$10.39 billionViewN/AView Earnings Details
2/2/2017Q416$1.74$1.87$9.88 billion$9.94 billionViewListenView Earnings Details
11/3/2016Q316$1.91$1.94$4.37 billion$9.90 billionViewN/AView Earnings Details
7/29/2016Q216$2.39$1.98$9.98 billion$9.89 billionViewListenView Earnings Details
5/6/2016Q116$2.16$2.32$9.98 billion$9.90 billionViewN/AView Earnings Details
2/4/2016Q415$1.80$1.87$9.52 billion$9.53 billionViewN/AView Earnings Details
11/6/2015Q315$2.18$2.28$9.51 billion$9.39 billionViewN/AView Earnings Details
7/30/2015Q215$2.38$2.55$9.53 billion$9.50 billionViewN/AView Earnings Details
4/30/2015Q115$1.85$1.96$9.28 billion$9.50 billionViewN/AView Earnings Details
2/5/2015Q414$1.65$1.69$8.89 billion$8.93 billionViewN/AView Earnings Details
10/30/2014Q314$1.81$1.95$8.64 billion$8.80 billionViewN/AView Earnings Details
7/31/2014Q214$1.85$1.96$7.61 billion$8.73 billionViewN/AView Earnings Details
5/1/2014Q114$1.54$1.83$7.72 billion$8.50 billionViewListenView Earnings Details
2/7/2014Q413$1.63$1.39$7.30 billion$8.15 billionViewListenView Earnings Details
10/31/2013Q313$1.62$1.89$7.24 billion$8.07 billionViewListenView Earnings Details
8/1/2013Q2 2013$1.60$1.78$7.38 billion$7.98 billionViewN/AView Earnings Details
5/2/2013Q1 2013$1.42$1.72$7.25 billion$8.18 billionViewListenView Earnings Details
2/7/2013Q4 2012$1.48$1.41$6.72 billion$7.62 billionViewListenView Earnings Details
11/1/2012Q312$1.36$1.71$6.63 billion$7.36 billionViewN/AView Earnings Details
8/2/2012$1.41$1.52ViewN/AView Earnings Details
5/3/2012$1.30$1.28ViewN/AView Earnings Details
2/2/2012$1.18$1.11ViewN/AView Earnings Details
10/28/2011$1.22$1.20ViewN/AView Earnings Details
8/4/2011$1.29$1.53ViewN/AView Earnings Details
5/5/2011$1.09$1.37ViewN/AView Earnings Details
2/3/2011$1.02$1.15ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Cigna Corporation (NYSE:CI)
2017 EPS Consensus Estimate: $9.61
2018 EPS Consensus Estimate: $10.87
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$2.36$2.56$2.45
Q2 20174$2.44$2.87$2.58
Q3 20174$2.30$2.68$2.42
Q4 20174$2.06$2.26$2.17
Q1 20181$2.81$2.81$2.81
Q2 20181$2.87$2.87$2.87
Q3 20181$2.71$2.71$2.71
Q4 20181$2.48$2.48$2.48
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Cigna Corporation (NYSE:CI)
Most Recent Dividend:4/10/2017
Annual Dividend:$0.04
Dividend Yield:0.02%
Dividend Growth:0.00% (3 Year Average)
Payout Ratio:0.46% (Trailing 12 Months of Earnings)
0.40% (Based on This Year's Estimates)
0.35% (Based on Next Year's Estimates)
Dividend Payments by Quarter for Cigna Corporation (NYSE:CI)

Dividend History by Quarter for Cigna Corporation (NYSE CI)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/22/2017quarterly$0.040.03%3/8/20173/10/20174/10/2017
2/25/2016annual$0.040.03%3/9/20163/11/20164/11/2016
2/26/2015annual$0.040.03%3/10/20153/12/20154/10/2015
2/26/2014quarterly$0.040.05%3/10/20143/12/20144/9/2014
3/1/2013annual$0.040.07%3/8/20133/12/20134/10/2013
2/28/2013quarterly$0.043/12/20134/10/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Cigna Corporation (NYSE:CI)
Insider Ownership Percentage: 1.30%
Institutional Ownership Percentage: 87.95%
Insider Trades by Quarter for Cigna Corporation (NYSE:CI)
Institutional Ownership by Quarter for Cigna Corporation (NYSE:CI)
Insider Trades by Quarter for Cigna Corporation (NYSE:CI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/13/2017William D. ZollarsDirectorSell1,232$187.23$230,667.36View SEC Filing  
9/12/2017Isaiah Harris, Jr.ChairmanSell247$185.27$45,761.69View SEC Filing  
8/16/2017Lisa R BacusEVPSell2,236$179.95$402,368.20View SEC Filing  
8/9/2017Mary T HoeltzelVPSell525$177.59$93,234.75View SEC Filing  
8/8/2017Michael W TriplettInsiderSell3,700$174.96$647,352.00View SEC Filing  
8/7/2017Jason D SadlerInsiderSell37,756$176.16$6,651,096.96View SEC Filing  
7/24/2017Jane E. Md HenneyDirectorSell600$174.14$104,484.00View SEC Filing  
7/21/2017Matthew G MandersInsiderSell24,357$175.01$4,262,718.57View SEC Filing  
6/19/2017David CordaniCEOSell153,168$170.20$26,069,193.60View SEC Filing  
6/14/2017Michael W TriplettInsiderSell1,439$166.89$240,154.71View SEC Filing  
6/6/2017Mary T HoeltzelVPSell500$166.70$83,350.00View SEC Filing  
6/5/2017Jason D SadlerInsiderSell1,727$164.59$284,246.93View SEC Filing  
6/2/2017Matthew G MandersInsiderSell6,000$165.00$990,000.00View SEC Filing  
5/24/2017Lisa R BacusEVPSell11,455$161.57$1,850,784.35View SEC Filing  
5/17/2017Nicole S JonesEVPSell20,312$160.04$3,250,732.48View SEC Filing  
4/24/2017Jane E. Md HenneyDirectorSell600$156.92$94,152.00View SEC Filing  
4/10/2017Jason D SadlerInsiderSell4,213$152.01$640,418.13View SEC Filing  
2/27/2017David CordaniCEOSell43,637$147.78$6,448,675.86View SEC Filing  
2/27/2017Matthew G MandersInsiderSell8,309$146.54$1,217,600.86View SEC Filing  
2/27/2017Thomas A MccarthyCFOSell4,464$146.54$654,154.56View SEC Filing  
12/20/2016Jason D SadlerInsiderSell2,000$138.10$276,200.00View SEC Filing  
11/7/2016John M MurabitoEVPSell58,822$125.09$7,358,043.98View SEC Filing  
10/31/2016Jason D SadlerInsiderSell4,000$121.80$487,200.00View SEC Filing  
8/17/2016Mary T HoeltzelVPSell500$132.28$66,140.00View SEC Filing  
12/8/2015Isaiah Harris JrChairmanSell333$137.00$45,621.00View SEC Filing  
11/16/2015Herbert A. FritchinsiderSell40,157$133.18$5,348,109.26View SEC Filing  
10/15/2015Herbert A. FritchinsiderSell39,202$136.66$5,357,345.32View SEC Filing  
9/15/2015Herbert A. FritchinsiderSell39,174$139.66$5,471,040.84View SEC Filing  
8/17/2015Herbert A FritchInsiderSell38,489$144.36$5,556,272.04View SEC Filing  
7/15/2015Herbert A FritchInsiderSell37,918$155.96$5,913,691.28View SEC Filing  
6/15/2015Herbert A FritchInsiderSell38,045$145.15$5,522,231.75View SEC Filing  
6/8/2015Isaiah Harris JrChairmanSell319$139.48$44,494.12View SEC Filing  
4/15/2015Herbert A FritchInsiderSell38,080$132.99$5,064,259.20View SEC Filing  
3/16/2015Herbert A FritchInsiderSell38,377$124.40$4,774,098.80View SEC Filing  
3/9/2015Isaiah Harris JrChairmanSell369$120.64$44,516.16View SEC Filing  
3/2/2015Nicole S JonesEVPSell8,659$121.88$1,055,358.92View SEC Filing  
2/10/2015Mary T HoeltzelCAOSell6,805$113.29$770,938.45View SEC Filing  
1/15/2015Herbert A FritchInsiderSell35,864$107.04$3,838,882.56View SEC Filing  
12/15/2014Herbert A FritchInsiderSell35,929$101.67$3,652,901.43View SEC Filing  
12/8/2014Isaiah Harris JrChairmanSell437$104.60$45,710.20View SEC Filing  
12/1/2014John M MurabitoEVPSell12,000$102.76$1,233,120.00View SEC Filing  
9/10/2014Jane E Md HenneyDirectorSell475$95.98$45,590.50View SEC Filing  
8/18/2014Jason D SadlerInsiderSell11,000$93.02$1,023,220.00View SEC Filing  
8/1/2014Isaiah Harris JrChairmanSell1,066$90.22$96,174.52View SEC Filing  
6/13/2014Thomas A MccarthyCFOSell7,206$90.26$650,413.56View SEC Filing  
6/12/2014Nicole S JonesEVPSell1,882$91.02$171,299.64View SEC Filing  
6/11/2014John M MurabitoEVPSell17,519$91.25$1,598,608.75View SEC Filing  
6/10/2014David CordaniCEOSell133,523$89.73$11,981,018.79View SEC Filing  
6/2/2014David D GuilmetteInsiderSell6,591$90.19$594,442.29View SEC Filing  
5/13/2014Jason SadlerInsiderSell6,145$88.50$543,832.50View SEC Filing  
5/12/2014Matthew MandersInsiderSell9,905$87.79$869,559.95View SEC Filing  
5/8/2014Jason SadlerInsiderSell7,810$85.59$668,457.90View SEC Filing  
5/7/2014Mary HoeltzelCAOSell3,000$85.00$255,000.00View SEC Filing  
3/14/2014John MurabitoEVPSell29,843$76.70$2,288,958.10View SEC Filing  
3/14/2014Mary HoeltzelCAOSell5,333$77.72$414,480.76View SEC Filing  
9/12/2013Nicole JonesEVPSell1,530$82.35$125,995.50View SEC Filing  
9/6/2013John M MurabitoEVPSell24,333$81.07$1,972,676.31View SEC Filing  
8/16/2013Jason SadlerInsiderSell13,261$77.81$1,031,838.41View SEC Filing  
8/14/2013Mary HoeltzelCAOSell8,664$78.26$678,044.64View SEC Filing  
8/7/2013John MurabitoEVPSell78,589$77.89$6,121,297.21View SEC Filing  
6/13/2013David CordaniCEOSell58,705$68.63$4,028,924.15View SEC Filing  
6/12/2013Matthew G MandersInsiderSell36,868$68.75$2,534,675.00View SEC Filing  
6/12/2013Nicole S JonesEVPSell15,306$70.08$1,072,644.48View SEC Filing  
6/5/2013Isaiah Harris JrChairmanSell5,312$67.40$358,028.80View SEC Filing  
3/11/2013Mary T HoeltzelCAOSell5,712$60.50$345,576.00View SEC Filing  
3/6/2013Eric C WisemanDirectorBuy4,200$59.30$249,060.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Cigna Corporation (NYSE:CI)
Latest Headlines for Cigna Corporation (NYSE:CI)
Source:
DateHeadline
americanbankingnews.com logoCigna Corporation (CI) Receives New Coverage from Analysts at BMO Capital Markets
www.americanbankingnews.com - October 16 at 6:46 PM
americanbankingnews.com logoCigna Corporation (CI) versus The Competition Financial Contrast
www.americanbankingnews.com - October 16 at 6:28 PM
finance.yahoo.com logoCigna-HealthSpring’s Medicare Advantage Plans for 2018 Emphasize Affordable, Stable Premiums and Coordinated Care by Local Physicians
finance.yahoo.com - October 16 at 5:58 PM
finance.yahoo.com logoTrump's Decision To Cut Cost-Sharing Subsidies Hurt UnitedHealth And 4 Other Health Care Stocks
finance.yahoo.com - October 16 at 5:58 PM
finance.yahoo.com logoHow Kansas, Missouri health markets will respond to Trump orders
finance.yahoo.com - October 16 at 5:58 PM
benzinga.com logoCigna Says End To ACA Subsidies Would Likely Increase Premiums - Benzinga
www.benzinga.com - October 13 at 10:48 PM
americanbankingnews.com logoCigna Corporation (CI) Price Target Increased to $221.00 by Analysts at Jefferies Group LLC
www.americanbankingnews.com - October 13 at 7:02 PM
feeds.benzinga.com logoCigna Says End To ACA Subsidies Would Likely Increase Premiums
feeds.benzinga.com - October 13 at 3:37 PM
finance.yahoo.com logoNew Strong Buy Stocks for October 12th
finance.yahoo.com - October 12 at 5:57 PM
americanbankingnews.com logoCigna Corporation (CI) Given Consensus Rating of "Buy" by Analysts
www.americanbankingnews.com - October 11 at 4:44 PM
americanbankingnews.com logoCritical Contrast: Cigna Corporation (CI) & Its Competitors
www.americanbankingnews.com - October 11 at 4:24 PM
americanbankingnews.com logoCigna Corporation (CI) and Its Competitors Critical Comparison
www.americanbankingnews.com - October 11 at 8:38 AM
nasdaq.com logoWhy the Earnings Streak Will Continue for Cigna (CI) - Nasdaq
www.nasdaq.com - October 10 at 11:27 PM
seekingalpha.com logoMedical Services Stocks: What Best Wealth-Builders Here Now?
seekingalpha.com - October 10 at 6:25 PM
finance.yahoo.com logoWhy the Earnings Streak Will Continue for Cigna (CI)
finance.yahoo.com - October 10 at 6:25 PM
americanbankingnews.com logoCigna Corporation (CI) Raised to Buy at Zacks Investment Research
www.americanbankingnews.com - October 9 at 11:24 AM
msn.com logoCollegium Rallies On 'Value-Based Contract' With Cigna; Here's What It Means
www.msn.com - October 6 at 10:30 PM
bizjournals.com logoCorporate Philanthropy: Cigna employees make big impact on communities across the state
www.bizjournals.com - October 6 at 5:28 PM
americanbankingnews.com logoCigna Corporation (CI) & Its Competitors Financial Analysis
www.americanbankingnews.com - October 6 at 2:08 AM
investorplace.com logoStrong Buy Ranking for Cigna (CI) Kept - Investorplace.com
investorplace.com - October 5 at 4:19 PM
businesswire.com logoCigna is Committed to Reducing Opioid Use: Removing OxyContin ... - Business Wire (press release)
www.businesswire.com - October 5 at 4:19 PM
benzinga.com logoCollegium Rallies On 'Value-Based Contract' With Cigna; Here's What It Means - Benzinga
www.benzinga.com - October 5 at 4:19 PM
businesswire.com logoCigna Corporation's Third Quarter 2017 Earnings Release Details - Business Wire (press release)
www.businesswire.com - October 5 at 4:19 PM
finance.yahoo.com logoCigna won't cover OxyContin prescriptions for 2018
finance.yahoo.com - October 5 at 4:19 PM
finance.yahoo.com logoNews Update - Late Morning
finance.yahoo.com - October 5 at 4:19 PM
finance.yahoo.com logoCigna cuts coverage for painkiller OxyContin
finance.yahoo.com - October 5 at 4:19 PM
finance.yahoo.com logoCigna is creating incentive to keep opioid doses low: Dr....
finance.yahoo.com - October 5 at 4:19 PM
finance.yahoo.com logoCigna will no longer cover opioid OxyContin as preferred option next year
finance.yahoo.com - October 5 at 4:19 PM
finance.yahoo.com logoWill benefit managers jump in with Cigna's move to pull OxyContin?
finance.yahoo.com - October 5 at 4:19 PM
msn.com logoCigna won't cover OxyContin prescriptions for 2018
www.msn.com - October 5 at 11:24 AM
finance.yahoo.com logoOne of America's largest health insurers just stopped covering a main opioid painkiller
finance.yahoo.com - October 5 at 11:24 AM
americanbankingnews.com logoContrasting Cigna Corporation (CI) and Its Rivals
www.americanbankingnews.com - October 5 at 9:22 AM
investorplace.com logoStrong Buy Ranking for Cigna (CI) Kept
investorplace.com - October 4 at 5:14 PM
finance.yahoo.com logoCigna Corporation’s Third Quarter 2017 Earnings Release Details
finance.yahoo.com - October 4 at 3:53 PM
finance.yahoo.com logoCigna is Committed to Reducing Opioid Use: Removing OxyContin from Group Commercial Drug Lists on 1/1/18
finance.yahoo.com - October 4 at 3:53 PM
americanbankingnews.com logoAnalyzing Cigna Corporation (CI) and Anthem (ANTM)
www.americanbankingnews.com - October 4 at 4:32 AM
prnewswire.com logo2017 Cigna 360° Well-being Survey - Positive Aspects of Working Overseas Often ...
www.prnewswire.com - October 2 at 4:56 PM
finance.yahoo.com logo2017 Cigna 360° Well-being Survey - Positive Aspects of Working Overseas Often Overshadowed by Health and Financial Concerns
finance.yahoo.com - October 2 at 4:56 PM
americanbankingnews.com logoCigna Corporation (CI) Expected to Post Quarterly Sales of $9.89 Billion
www.americanbankingnews.com - October 1 at 1:30 PM
forbes.com logoCigna Will Continue To Sell Obamacare In Six States
www.forbes.com - September 30 at 3:24 PM
finance.yahoo.com logoDid Cigna Corporation (CI) Create Value For Shareholders?
finance.yahoo.com - September 29 at 4:14 PM
americanbankingnews.com logo$2.34 Earnings Per Share Expected for Cigna Corporation (CI) This Quarter
www.americanbankingnews.com - September 29 at 6:22 AM
reuters.com logoBRIEF-India's Cigna TTK Health Insurance says gets regulator nod for raising Cigna Corp stake in JV
www.reuters.com - September 28 at 5:10 PM
forbes.com logoWant To Engage Millennials? Try Corporate Social Responsibility
www.forbes.com - September 28 at 8:35 AM
reuters.com logoBRIEF-Rennova Health's Labs win appeal in the Eleventh Circuit Court Of Appeals in CIGNA suit
www.reuters.com - September 25 at 12:31 PM
americanbankingnews.com logoContrasting UnitedHealth Group (UNH) and Cigna Corporation (CI)
www.americanbankingnews.com - September 23 at 9:10 AM
finance.yahoo.com logoHealthcare Stocks Soar After McCain Rejects Obamacare Repeal
finance.yahoo.com - September 22 at 9:12 PM
businesswire.com logoEconomist Intelligence Unit Survey, Sponsored by Cigna, Reveals Americans' Views on Opioid Addiction - Business Wire (press release)
www.businesswire.com - September 22 at 10:03 AM
americanbankingnews.com logoCigna Corporation (CI) & Anthem (ANTM) Financial Review
www.americanbankingnews.com - September 21 at 8:52 AM
businesswire.com logoCigna Announces Early Results of Debt Tender Offers | Business Wire - Business Wire (press release)
www.businesswire.com - September 20 at 5:57 PM

Social

Chart

Cigna Corporation (CI) Chart for Tuesday, October, 17, 2017

This page was last updated on 10/17/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.